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(wileyoAbstract—Animals have evolved diverse protective mechanisms for responding to toxic chemicals of both natural and anthropogenic
origin. From a governmental regulatory perspective, these protective responses complicate efforts to establish acceptable levels of
chemical exposure. To explore this issue, we considered vertebrate endocrine systems as potential targets for environmental
contaminants. Using the hypothalamic-pituitary-thyroid (HPT), hypothalamic-pituitary-gonad (HPG), and hypothalamic-pituitary-
adrenal (HPA) axes as case examples, we identified features of these systems that allow them to accommodate and recover from
chemical insults. In doing so, a distinction was made between effects on adults and those on developing organisms. This distinction
was required because endocrine system disruption in early life stages may alter development of organs and organ systems, resulting in
permanent changes in phenotypic expression later in life. Risk assessments of chemicals that impact highly regulated systems must
consider the dynamics of these systems in relation to complex environmental exposures. A largely unanswered question is whether
successful accommodation to a toxic insult exerts a fitness cost on individual animals, resulting in adverse consequences for
populations. Mechanistically based mathematical models of endocrine systems provide a means for better understanding accom-
modation and recovery. In the short term, these models can be used to design experiments and interpret study findings. Over the long
term, a set of validated models could be used to extrapolate limited in vitro and in vivo testing data to a broader range of untested
chemicals, species, and exposure scenarios. With appropriate modification, Tier 2 assays developed in support of the U.S.
Environmental Protection Agency’s Endocrine Disruptor Screening Program could be used to assess the potential for accommodation
and recovery and inform the development of mechanistically based models. Environ. Toxicol. Chem. 2011;30:39–51.
# 2010 SETACKeywords—Accommodation Recovery Developmental programming Endocrine disruption Endocrine axisINTRODUCTION
Animals have evolved diverse protective mechanisms
for responding to toxic chemicals of both natural and anthro-
pogenic origin. For example, signaling pathways mediated
by activation of nuclear transcription factors result in coordi-
nated production of enzymes, binding proteins, and membrane
transporters that detoxify, sequester, and eliminate foreign
substances [1]. Additional pathways recognize and repair cell
damage after toxicant-induced injury (e.g., the DNA-response
pathway; [2]). These protective responses may allow animals
to function normally despite exposure to chemicals that at
higher concentrations would cause adverse toxicological
effects.
For continuous or frequently occurring exposures,
selection of animals that successfully respond to the insult
may result in populations resistant to a specific chemical orented at the SETAC Pellston Workshop, Forest Grove, OR, USA,
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39chemical class. For example, killifish (Fundulus heteroclitus)
and tomcod (Microgadus tomcod) that inhabit sites contami-
nated with polychlorinated biphenyls (PCBs), polychlo-
rinated dibenzo-p-dioxins (PCDDs), or polycyclic aromatic
hydrocarbons (PAHs) become resistant to PCB-, PCDD-,
or PAH-induced lethality, developmental toxicity, and
induction of cytochrome P4501A (CYP1A) [3]. Similarly,
aquatic insects may develop resistance to high levels of
heavy metal contamination. This response depends on the
magnitude, duration, and spatial extent of metal exposure, as
well as movements of animals within the environment [4].
Analogous findings have been reported for target pest
species (insect, fungal, and weed populations) exposed to
pesticides.
From a governmental regulatory perspective, the ability
of animals to accommodate and recover from chemical
insults is problematic because it complicates efforts to establish
acceptable levels of exposure. The challenge of dealing with
these responses in the context of human health risk assessment
was recognized in a report by the National Research Council
(NRC) entitled Toxicity Testing in the 21st Century [5].
As presented in the NRC report, Figure 1 shows a dichotomous
framework that distinguishes between normal biological
Fig. 1. Biological responses to toxic chemicals. This figure was originally presented by Andersen et al. [89] and later reproduced by the National Research Council
[5]. It is reprinted here with permission. The figure highlights the role of accommodation (termed adaptationby the authors) in the context of chemical effects at the
cellular level, and indicates that toxicity occurs only after these protective responses are overwhelmed.
40 Environ. Toxicol. Chem. 30, 2011 J.W. Nichols et al.function and a divergent pathway that leads to toxic effects.
Within this framework, accommodation (referred to by the
authors as adaptation) is viewed as a loop that restores the
system to normal function. The report focused on toxic effects
at the cellular level of biological organization, and the potential
for accommodation was discussed primarily in this context. The
authors noted, however, that cellular response information must
be related to the response of an intact biological system.
To accomplish this goal, one must understand accommodation
occurring at higher levels of biological organization.
The purpose of the current paper is to summarize the findings
of a workgroup that was organized as part of a SETAC Pellston
Workshop entitled A Vision and Strategy for Predictive
Ecotoxicology in the 21st Century: Defining Adverse Outcome
Pathways Associated with Ecological Risk [6]. The charge to
the workgroup was to better understand what differentiates
successful accommodation and recovery from system failure
and to discuss how this information can be incorporated into
computational models of chemical effects. Chemical effects
on vertebrate endocrine systems were identified as a focus
for discussion, in part because of existing interest in endocrine
disruption as a chemical mode-of-action and also because
endocrine systems possess a demonstrated ability to accommo-
date and recover from chemical insults. In this report, we
describe features of endocrine systems that allow them to accom-
modate and recover from chemical insults, review studies that
illustrate these responses in ecologically relevant species, and
describe efforts to model chemical effects using computational
approaches. In concluding sections, we discuss accommodation
and recovery in the context of ecological risk assessment
and identify research needed to better predict these responses.
TERMS AND DEFINITIONS
Scientists that study the responses of biological systems
to external stressors use a variety of terms to describe specificresponse categories. For clarity, we begin by defining our use
of terms and describe their relationships to one another.
The term accommodation refers to any response of a
biological system to an external stressor that tends to restore
the system to its normal or baseline condition or establishes a
new set point. Here the term external is relative to the level
of biological organization at which accommodation occurs
and could, for example, refer to a stressor operating at the cell,
whole organism, or population level. In toxicology, accommo-
dation occurs as a response to a chemical stressor and generally
refers to restoration of biological function despite continued
exposure to the compound. We use accommodation instead
of adaptation (as used in the NRC report [5]) to describe
proximate physiological responses and mechanisms so as to
avoid confusion with use of the term adaptation in an ultimate,
evolutionary context.
A diverse array of physiological systems functions to main-
tain relative constancy of the internal environment (e.g., in cells
or the entire organism). Some of these systems tightly regulate a
physical–chemical property of the organism (e.g., osmolarity,
oxygen partial pressure), whereas others maintain the concen-
tration of an endogenous substance within narrow limits (e.g.,
pH, glucose). This type of physiological control is termed
homeostasis. Other systems can respond by adjusting the con-
centration of an endogenous substance (generally a ligand for a
macromolecular receptor) or by changing the set point for one
or more physiological parameters (e.g., blood pressure or heart
rate). This accommodation through change is called allostasis
[7,8]. Examples of allostatic systems include the autonomic
nervous system (ANS) and the hypothalamic-pituitary-adrenal
(HPA) axis. Importantly, the systems responsible for homeo-
stasis and allostasis may themselves change during the lifetime
of an animal because of developmental and aging processes, or
in response to the external environment.
The term recovery refers to restoration of biological function
after withdrawal of a stressor. Other terms describe different
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developmental plasticity, and developmental programming.
Performance is an individual-level measure of physiological
state and is what whole-animal bioassays typically measure.
Fitness refers to the relative probability of survival and repro-
duction for a genotype and is inferred from an evaluation
of performance measures in the context of life history and
reproductive strategies. Developmental plasticity is the
property of a given genotype to produce different phenotypes
in response to environmental conditions experienced during
development. Under natural conditions, developmental plasti-
city may generate adaptive morphological, physiological,
or behavioral traits that promote survival. The term develop-
mental programming encompasses a mechanism by which
developmental plasticity occurs and may involve epigenetic
changes that alter gene expression. The term developmental
programming is not specific to any particular taxon. As such,
it has broader application than the term fetal programming,
which is often used to describe developmental programming
in mammals.
A FOCUS ON ENDOCRINE SYSTEMS
Although chemical effects on endocrine systems have been
studied for decades, current interest in this topic is attributable
in large part to works published by Theo Colborn and
colleagues [9]. These authors suggested that a large number
of environmental contaminants may disrupt endocrine systems
during critical stages of development, resulting in adverse
outcomes in wildlife and humans. Scientists continue to debate
whether these effects are widespread or restricted to a small
number of compounds or a few geographically localized
hotspots [10]. Nevertheless, governmental agencies in NorthFig. 2. Neuroendocrine regulation within the hypothalamic-pituitary-thyroid (H
Hierarchical closed-loop regulation begins at the hypothalamus, which produces
hormones. Primary feedback regulation occurs in the hypothalamus and pituitary via
gonadal hormones produced and secreted by the target glands. The actions of pe
mechanisms at their intracellular sites of action throughout the organism. TRH¼ thy
¼ gonadotropin-releasing hormone; TSH ¼ thyroid-stimulating hormone; ACTH ¼
GH ¼ growth hormone; FSH ¼ follicle-stimulating hormone; T4 ¼ thyroxine; T3America and Europe have established programs to identify
and regulate compounds that have potential to impact endo-
crine systems (http://www.epa.gov/scipoly/oscpendo/pubs/
edspoverview/finalrpt.htm; http://europa.eu/eur-lex/en/com/
cnc/1999/com1999_0706en01.pdf; accessed June 26, 2009).
A majority of research on environmental endocrine disruptors
has been focused on vertebrate species. This focus is reflected
within this report. The workgroup recognized, however, that
endocrine systems control the development and growth of most
(if not all) invertebrate species and chemicals that are used
to intentionally impact hormonally regulated development in
invertebrates constitute an important class of insecticides [11].
THE HPT, HPA, AND HPG AXES AS CASE EXAMPLES
To provide additional focus for discussion, the workgroup
considered the hypothalamic-pituitary-thyroid (HPT), -gonad
(HPG), and -adrenal (HPA) axes as case examples. Here
we describe the three axes in general terms, noting shared
structural attributes that allow these systems to respond to
various insults.
The three endocrine axes are represented schematically in
Figure 2. Each is controlled centrally by neurosecretory neurons
located in the anterior preoptic region and hypothalamus of the
brain. These neurons project axons to the median eminence,
where neurohormones are released into the pituitary portal
circulation (in bony fishes the axons terminate within the
pituitary gland, directly innervating pituitary cells). The neuro-
secretory neurons receive inputs from higher brain centers,
limbic structures, and the hindbrain and also are regulated
by hormones and metabolites in the blood circulation. Neuro-
hormones produced by these neurons regulate the secretion
of pituitary hormones to the general circulation. Many pituitaryPT), -adrenal (HPA), and -gonad (HPG) axis feedback control systems.
neurohormones that either stimulate or inhibit pituitary secretion of tropic
intracellular signal transduction initiated by circulating thyroid, adrenal, and
ripherally derived hormones are also controlled via an array of regulatory
rotropin-releasing hormone; CRH¼ corticotropin-releasing hormone; GnRH
adrenocorticotropic hormone; LH ¼ luteinizing hormone; PRL ¼ prolactin;
¼ 3,5,30-triiodothyronine.
Fig. 3. Presumptive spectrumof responses to chemical impacts on endocrine
systems. The costs and benefits to the organism of mounting a response are
arrayed along theY-axis. The magnitude of the stressor is arrayed along theX-
axis. Terms along the X-axis describe a spectrum of responses and potential
consequences: homeostasis ¼ maintenance of relative constancy through
normal feedback mechanisms; allostatic change ¼ change to one or more
components of the system itself as the organism strives to deal with
uncompensated stress; allostatic load ¼ permanent changes attributable to
repeated cycles of allostasis.
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lated by releasing factors and inhibited by release-inhibiting
factors. Pituitary hormones that act on other hormone-produc-
ing glands are called tropic hormones. These tropic hormones
control the secretion of hormones by peripheral endocrine
glands such as the thyroid, gonads, and adrenal cortex. Periph-
erally derived hormones act in turn on various target tissues to
coordinate a range of biological functions [12,13].
Peripherally derived hormones are transported in the blood-
stream bound to hormone-binding proteins. The hormones
enter cells in target tissues, either passively by diffusion
(steroids) or by active uptake via membrane transporters (thy-
roid hormones), and they may be metabolized to active or
inactive forms. Active hormones bind nuclear hormone recep-
tors, which act as transcription factors to regulate gene expres-
sion. Peripherally derived hormones also may interact with
receptors located on the plasma membrane, leading to activa-
tion or inhibition of intracellular kinases, or they may bind
to intracellular enzymes, regulating their activity.
Primary control of each endocrine axis is achieved by
negative feedback of peripherally derived hormones on the
hypothalamus and pituitary, which reduces the production
of tropic hormones. This closed-loop feedback structure allows
the system to maintain a relatively constant plasma hormone
concentration through a process of continuous readjustment.
When the system receives signals from the external environ-
ment (e.g., photoperiod, temperature, hydroperiod) or from
internal biological clocks, or responds to changes in circulating
metabolites or hormones, plasma hormone concentrations
can fluctuate above or below some mean baseline value. The
baseline for any particular hormone is context dependent and is
set by experience within the system extending over a period of
hours to weeks (i.e., physiological set points). These systems
are robust and are capable of adjusting in response to a diversity
of environmental insults, including interactions of xenobiotics
with one or more components of the system.
A PRESUMPTIVE SPECTRUM OF PHYSIOLOGICAL
RESPONSES
The functioning parts of an endocrine axis are separated
in time and space. Moreover, effects on one axis may impact the
function of another axis because of shared molecular substrates,
enzymatic reactions, and signaling pathways. Given this
complexity, impacts on the whole organism may be difficult
to predict from an impact on any single part of an endocrine
axis unless the effect is of an extreme nature such as prolonged
stimulation by a hormone receptor agonist or substantial
inhibition of hormone synthesis.
To provide a basis for further discussion, the workgroup
sought to describe a spectrum of possible responses of endo-
crine systems (Fig. 3). Because some of these responses are
poorly described, particularly in species of ecological concern,
this spectrum was labeled presumptive. When the magnitude
of stress on an endocrine axis is low, homeostasis can be
accomplished by normal feedback control, and a high level
of benefit is provided to the organism at little or no cost beyond
maintenance of the system itself. If stress on the system exceeds
the capacity for homeostatic control, the system may generate
an allostatic response, wherein the set point of the system may
change, generating a new stable state [14]. Long-term, stable
changes in physiological set points may involve epigenetic
changes in gene regulatory regions that lead to altered gene
expression [15]. These epigenetic changes include methylationof cytosine bases in gene promoter regions called CpG islands
and post-translational modifications to histones [16].
Such changes may lead to changes in hormone receptor expres-
sion or the activities of pathways responsible for hormone
biosynthesis. These changes may be beneficial (adaptive in
an evolutionary sense; i.e., tending to increase fitness), provided
that the functioning of the system is appropriate to the environ-
ment within which the organism lives. Mismatch between
the phenotype and the environment may result in reduced
fitness. Chronic stress in animals can result in permanent
changes that lead to disease [17]. This stress on the system,
which is often termed the allostatic load [8], has been docu-
mented in studies of the central nervous system, immune
system, and cardiovascular system [14]. To our knowledge,
the term allostatic load has not previously been used by
toxicologists. We introduce it here and use it to describe
potential impacts associated with long-term physiological
responses to endocrine-disrupting compounds.
At some point, a level of stress exceeds the animal’s ability
to fully compensate, and benefits of the system are lost even
as the cost of accommodation increases. If the magnitude of
exposure is high, the animal may proceed rapidly to death
(e.g., failure to complete metamorphosis). If the exposure and
resulting effects occur chronically, the animal may accumulate
an allostatic load, which could result in adverse fitness
consequences.
A complicating feature of endocrine systems is that
effects on a specific axis may be buffered by attributes of
the axis itself or the systems that it influences. For example,
the thyroid gland stores precursors to 3,5,30-triiodothyronine
(T3) and thyroxine (T4) as iodinated species within a protein
matrix called colloid. This storage form of thyroid hormones
may be sufficient to satisfy the needs of an organism for days,
weeks, or months (depending on the organism, its age, and other
factors), protecting the animal from short-term inhibitory
effects of chemicals on thyroid hormone synthesis. In addition,
effects elicited by a hormone may persist over time even
when its production declines because of the persistence of
cellular and molecular changes in target tissues. For example,
although thyroid hormone plays a critical role in amphibian
metamorphosis, the effect of a thyroid hormone synthesis
inhibitor on metamorphosis tends to be stage dependent, and
an exposure that occurs late in development may have little or
Fig. 4. Adverse outcome pathways for several chemicals that may impact the thyroid axis. Toxicants acting via different modes action may reduce thyroid
hormone production, resulting in similar consequences for the exposed organism. PCBs ¼ polychlorinated biphenyls; DDT ¼ dichlorodiphenyltrichloroethane;
NIS ¼ sodium-iodide symporter; T3 ¼ 3,5,30-triiodothyronine; T4 ¼ thyroxine.
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already been initiated [18,19].
ACCOMMODATION AND RECOVERY OF ENDOCRINE
SYSTEMS
A large number of compounds have been shown to impact
one or more endocrine axes. Figure 4 uses the adverse out-
come pathway [20] concept as an organizing principle to
illustrate this point. In this example, adverse outcome path-
ways are shown for five compounds that can impact the HPT
axis via three different mechanisms. Methimazole and ethyl-
enethiourea inhibit thyroid peroxidase, an enzyme that cata-
lyzes the incorporation of iodide into thyroglobulin, the
protein precursor for T3 and T4. Perchlorate competitively
inhibits the sodium-iodide symporter, a protein that transports
plasma iodide into the thyroid follicle cell, whereas PCBs and
DDT induce phase II metabolic pathways in the liver that
clear T3 and T4 from plasma. All three mechanisms can
reduce circulating levels of T3 and T4, potentially resulting
in adverse outcomes such as impaired development [21] and
metabolic dysfunction [22].
Although these adverse outcome pathways provide plausible
linkages between a specific initiating event and an adverse
outcome, they do not directly address the possibility of accom-
modation to these chemical insults. Instead, the arrows linking
molecular interactions to higher-order responses (cell ! organ/
tissue ! individual) presume that the dose is sufficient to cause
effects at all levels of biological organization. Accommodation
may be viewed, therefore, as a response that operates against
one or more of the arrows shown in Figure 4.
By its nature, accommodation to a chemical exposure is
difficult to demonstrate. How does one demonstrate that an
animal has responded to an insult when it appears to be
unaffected? Dose–response studies often result in identification
of treatment levels below which no effects were observed.
Traditionally, toxicologists have interpreted this finding in
terms of a threshold for toxicity. In most instances, however,
a range of dose levels may be present to which the animal
successfully responds, resulting in no measured effects
(as defined by the test endpoints). The apparent toxicity
threshold is therefore defined by the test endpoints as well
as by the animal’s ability to respond to real, albeit uncharac-
terized, effects.One way to demonstrate that accommodation has occurred
is to characterize the physiological response itself, including
its time course in relation to that of well-defined apical
endpoints. The structure/function of the HPT axis in amphibians
is well known, as is the mode of action by which many thyroid-
disrupting compounds act (Fig. 4). By integrating this informa-
tion, one may hypothesize likely elements of a compensatory
response and develop research tools needed to measure
them. Using this approach, several research groups have char-
acterized the effects of thyroid hormone synthesis inhibitors on
metamorphosis in Xenopus laevis tadpoles [23–25]. In each of
these studies, the authors observed histological changes (follicle
cell hypertrophy or hyperplasia) consistent with an increase
in circulating levels of thyroid stimulating hormone, as would
be expected if circulating T3/T4 levels declined (because of
reduced negative feedback). Importantly, these changes were
observed at treatment levels that resulted in impaired meta-
morphosis as well as one or more treatment levels that had no
discernible effect on development.
In recent work, the time course for this response and its
underlying mechanistic basis have been studied in detail. Optiz
et al. [26] found that genes that code for the sodium-iodide
symporter, thyroid peroxidase, and the thyroid-stimulating
hormone receptor were significantly up-regulated in tadpoles
exposed to perchlorate or ethylenethiourea. These responses
were observed at early time points (3–5 d), well in advance of
any effects on metamorphosis. Tietge et al. [27] exposed
tadpoles to concentrations of methimazole, perchlorate, or 6-
propyluracil that had been shown to inhibit metamorphosis after
14 d of exposure. Circulating levels of T4 declined after 6 d of
exposure. This effect was accompanied by an increase in thyroid
cell number, suggesting compensation via cell proliferation. Both
observations were preceded in time, however, by a decrease in T4
stored within the gland (exposure day 2). This observation
suggests that, despite a progressive decrease in stored T4, animals
were able to maintain circulating levels of T4 for several days.
Several studies have demonstrated that endocrine systems
can recover after brief exposures to various chemical classes.
For example, rainbow trout exposed for 30 d to an environ-
mentally relevant mixture of PCBs exhibited a decreased level
of deiodinase activity and an increased number of thyroid
epithelial cells [28]. Both measures of thyroid system status
returned to control levels after a 20-d depuration period. Li et al.
[29] found that partial-to-full recovery of the rare minnow
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histopathology, plasma thyroid hormone, transthyretin deiodi-
nase, and thyroid hormone receptor messenger RNA in the
liver and brain) occurred during a 28-d depuration period in
clean water after 28 d of exposure to 3-amino-1,2,4 triazole
(amitrole). The extent of recovery was dependent, however, on
sex and the endpoint measured. Villeneuve et al. [30] reported
that endocrine-related effects resulting from a short-term (8-d)
exposure of fathead minnows to fadrozole were fully reversible
after an 8-d recovery period in clean water.
The effect of 17a-ethynylestradiol (EE2) on the HPG axis in
male zebrafish provides a particularly good example of recov-
ery from exposure to an endocrine-disrupting compound. EE2 is
a synthetic estrogen receptor agonist that is widely used as a
reference reproductive toxicant in vertebrate animal models.
Two studies have examined recovery after short-term exposure
of juvenile or adult males to EE2. Van den Belt et al. [31]
reported that 6-to-8-month-old adults exposed to 10 or 25 ng/L
EE2 for 24 d exhibited a significant decrease in the testis
somatic index and presence of mature sperm; however, all fish
fully recovered after a 24-d recovery period in clean water.
Maack and Segner [32] exposed 43 d postfertilization (dpf)
zebrafish to 1.7, 3, or 10 ng/L EE2 for 28 d, resulting in 85, 100,
and 100% of fish, respectively, with ovarian tissue. Despite a
complete reversal in gonadal phenotype at the two highest
treatment levels, these authors reported that, after a 119-d
recovery period, male fish were present, and testicular
tissue morphology was not significantly different from that
of controls.
Five additional studies have evaluated recovery after
long-term exposures of young (0–2 dpf) zebrafish to the juvenile
hermaphroditic stage (75–90 dpf) or premature/mature gonad
stage (120 dpf). Van den Belt et al. [31] found that exposure of
newly hatched zebrafish to 0.1, 1, 10, or 25 ng/L EE2 for 90 days
resulted in approximately 40, 40, 70, and 100%, respectively, of
total fish with undifferentiated gonads. After a recovery period
of 150 d, all male gonads were fully differentiated, and there
were no significant differences in testis somatic index compared
with controls. In contrast to these findings, Nash et al. [33]
exposed 1 dpf zebrafish to 0.5 or 5 ng/L EE2 for 75 d and then
allowed them to recover for 150 d. At the end of the recovery
period, male fish exhibited histological alterations in the testis,
including extensive sperm duct malformations, presence of
ovarian cavities, variations in the frequency of testicular cell
types, and ciliation of sperm ducts. Xu et al. [34] exposed 2 dpf
zebrafish to 0.4, 2, and 10 ng/L EE2 for 88 d followed by a
recovery period of 90 d. Exposure to 2 and 10 ng/L EE2 resulted
in a significant increase in the number of fish containing ovarian
or undifferentiated tissue at the end of the exposure period.
Although no significant differences in sex ratios were seen after
the recovery period, a significant percentage of males exhibited
malformations of the sperm duct, altered proportions of germ
cell types, and reduced number of spermatozoa. Larsen et al.
[35] observed partial recovery of 0 dpf zebrafish exposed for
120 d to 5 ng/L EE2 and allowed to recover for 8 months.
Longer exposure or varying recovery periods do not appear
to affect the ability of male zebrafish to recover from EE2
exposure. Schäfers et al. [36] exposed 0 dpf zebrafish to 10 ng/L
EE2 for 177 d followed by a recovery period of 108 d. Although
100% of fish contained ovarian tissue after EE2 exposure, 25%
of these fish recovered and developed mature testicular tissue.
Fenske et al. [37] exposed 0 dpf zebrafish to 3 ng/L EE2 for 42 d
followed by a recovery period of 33, 76, or 134 d; these authors
also exposed 0 dpf zebrafish to 3 ng/L EE2 for 118 d followedby a 58-d recovery period. Although gonadal effects were
not measured at the end of the exposure period, these authors
reported that, based on gonadal histology, partial-to-full
recovery occurred for all exposure and recovery periods.
Collectively, research on zebrafish has shown that animals
exposed to EE2 can recover from effects on the HPG axis.
Interestingly, although most of these studies demonstrated that
fish can partially or fully recover based on gonadal histology
and fecundity tests (as assessed by female egg production),
most efforts showed that short- or long-term EE2 exposure can
result in long-term impacts on male fertility (as assessed by
fertilization success [32–34,36,37]). Thus, these studies high-
light the importance of endpoint selection for evaluation
of recovery and illustrate the importance of assessing potential
fitness costs associated with chemically mediated disruption
of the HPG axis. This work also shows the value of using
standardized testing protocols to facilitate comparisons among
efforts.
Endocrine disrupting effects on developing systems
Epigenetic mechanisms of gene regulation acting during
early development play an important role in programming
phenotypic expression later in life [38]. In humans, develop-
mental programming may occur as a response to systemic stress
(e.g., malnutrition) and can cause adverse long-term health
effects [15,39]. Similar mechanisms may, however, contribute
to species survival by providing a means by which animals
match their phenotype to prevailing environmental conditions,
an outcome commonly referred to as developmental plasticity.
Developmental plasticity has been demonstrated in virtually
all groups of plants and animals, although particularly good
examples come from research on amphibians. Studies by
amphibian ecologists have shown that environmental condi-
tions experienced during the larval stage can affect metamor-
phic timing, body size, and the morphology of tadpoles and
adults [19,40]. This developmental plasticity may confer a
selective advantage to individuals that respond in an appropriate
manner to changing conditions (e.g., accelerated metamorpho-
sis in response to declining water levels), although changes such
as reduced body size also may result in reduced fitness.
Research with mammals has shown that the HPA axis
plays an important role in developmental programming that
occurs as a response to stress. The molecular and physiological
mechanisms involved in this response appear to be conserved
in lower vertebrates. For example, X. laevis tadpoles placed on a
restricted diet exhibited a reduced body size at metamorphosis
and elevated levels of whole body corticosterone when com-
pared with controls [41]. Exposure of X. laevis tadpoles to
exogenous corticosterone resulted in similar impacts on
metamorphosis. Previous studies with other Anuran species
have resulted in similar findings [42,43]. Hu et al. [41] went
further, however, and evaluated the long-term recovery of
frogs after metamorphosis. Tadpoles placed on a restricted diet
exhibited catch-up growth when transferred to a normal diet but
exhibited long-term elevations in whole-body corticosterone
content. Subsequent immunohistochemical studies showed that
early exposure to elevated levels of corticosterone as a tadpole
resulted in decreased glucocorticoid receptor densities in discrete
regions of the central nervous system of juvenile frogs. It is not
clear whether these changes would have adverse health conse-
quences for adult amphibians. Research with mammals suggests,
however, that early life nutritional deficits can result in profound
effects on adult physiology and behavior [44].
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the current discussion of accommodation and recovery is
threefold. First, because developmental programming can be
influenced by hormones, chemicals that impact endocrine axes
could impair the ability of animals to respond to changing
environmental conditions. Second, because impacts on devel-
opmental programming are thought to be limited to early life
stages, compounds that impair endocrine function may produce
different effects in early versus late developmental stages.
Third, phenotypic changes associated with developmental pro-
gramming may result in the establishment of a new steady-state
condition, distinct from the steady-state of unstressed animals.
The toxicological relevance of developmental programming
has been demonstrated in several studies with mammals [16].
These efforts showed that exposure to endocrine-disrupting
chemicals during early development can result in permanent
functional changes that are not realized until later in life,
including reproductive dysfunction and tumor promotion. Sim-
ilar data from ecologically relevant species are more limited.
King Heiden [45] showed that transient exposure of zebrafish to
2,3,7,8- tetrachlorodibenzo-p-dioxin during early development
resulted in latent toxicity in adults, and it was suggested that
developmental programming was responsible for this outcome.
Surprisingly, the offspring of these fish also exhibited increased
mortality, suggesting that chemical effects were transgenera-
tional. Although this result may have been caused by direct
effects on the genome (i.e., mutations), epigenetic changes are
also heritable [46,47].
PREDICTING CHEMICAL IMPACTS ON ENDOCRINE SYSTEMS
An expanded view of accommodation and recovery
Using as a starting point the paradigm for toxicity described
in the NRC report [5] and shown here as Figure 1, we sought
to develop a broader description of accommodation and recov-
ery relevant to ecological risk assessment of chemicals that
impact vertebrate endocrine systems. Figure 5 illustrates thisFig. 5. Expanded vision of accommodation and recovery for chemicals that impact e
normal feedback mechanisms; allostatic change¼ change to one or more component
developmental programming ¼ epigenetic changes that may occur in response to ch
phenotypes. The relative fitness of phenotypes A, B, and C depends on the envirobroader vision. In Figure 5, the spectrum of physiological
responses described previously (homeostasis/allostasis ! allo-
static load ! morbidity) is arrayed along the line that represents
a departure from the original stable state. This figure also
includes the possible emergence of new stable states (pheno-
types B, C. . ., and so forth) that arise as a consequence of
developmental programming or epigenetic changes associated
with chronic accommodation (i.e., constituting an allostatic
load). Homeostasis and allostasis restore the system to a stable
state; however, allostatic responses function in part to maintain
the integrity of homeostatic systems and are viewed as possess-
ing a broader scope for accommodation. Both homeostasis
and allostasis may operate to restore either the original stable
state or any new stable states that emerge from stable epigenetic
changes.
Figure 5 is generic with respect to levels of biological
organization. Although homeostasis and allostasis ultimately
result in changes at the cellular level, coordinated control of
these changes is likely to involve multiple tissues and organs
operating as part of a physiological system. The altered
phenotypes in Figure 5 could refer to whole organisms.
These new phenotypes would be expected, however, to contain
altered cells and tissues.
Implied by an explicit recognition of altered phenotypes
in Figure 5 is a departure from the NRC figure, which relates
to differences between the goals of human health and ecological
risk assessment. In general, human health risk assessment tends
to focus on protection of individuals, whereas ecological
risk assessment tends to focus on protection of populations
and ecosystems (with the exception of threatened and endan-
gered species). This difference follows from historic legislation
authorizing these activities and reflects a fundamental differ-
ence in the valuation of humans and wildlife.
As a practical matter, directly evaluating chemical impacts
on populations or ecosystems is difficult. The potential for
adverse ecological consequences is therefore largely inferred
from information obtained by testing individual organisms, asndocrine systems. Homeostasis¼maintenance of relative constancy through
s of the system itself as the organism strives to deal with uncompensated stress;
emical exposure during early development resulting in the production of new
nment within which the phenotype is expressed.
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risk assessment. Therefore, the primary difference between
these activities relates to the identification and use of specific
toxicological endpoints. For human health risk assessment,
demonstrated toxic effects of any kind are generally viewed
as unacceptable. As such, endpoints used to support this activity
are often more sensitive than traditional apical endpoints.
For ecological risk assessment, acceptable endpoints must be
relevant to the maintenance of populations and ecosystems.
This has led to a reliance on endpoints such as mortality,
reproduction, and development [48]. Given these differences,
human health risk assessors would be unlikely to view the
emergence of an altered phenotype as an acceptable outcome.
Therefore, the simpler structure represented by Figure 1 may
suffice for the purpose of assessing chemical risks to humans.
How altered phenotypes might be viewed within the context
of an ecological risk assessment is unclear. We are not aware of
any risk assessments that have directly addressed this issue.
A critical question in this case would be whether these changes
have clear impacts on the standard set of assessment endpoints
(mortality, reproduction, and development).
Relating exposure to effect
Exposure patterns for anthropogenic chemicals in terrestrial
and aquatic ecosystems often possess a significant degree
of temporal and spatial variability. This variability is a function
of many factors, including chemical production and use
patterns, local climate, watershed hydrology, and soil character-
istics, as well as intrinsic physicochemical properties
(e.g., photolysis, volatilization, solubility, and potential
for microbial degradation) that, in combination with local
conditions, influence the degree of chemical transport and
persistence.
The normal functioning and dynamics of endocrine systems
in ecologically relevant taxa is likely to exhibit significant
temporal, intraspecies, and interspecies variability, depending
on local environmental and ecological conditions. Chemical
exposure frequency, magnitude, duration, and timing may
determine whether these systems can accommodate or recover
from chemical exposure, and whether these responses result in
a selection pressure that results in sustained change at the
population level. A better understanding of temporal and spatial
variability of chemical exposure relative to the dynamics
of vertebrate endocrine systems is therefore needed to accu-
rately predict the potential for short- or long-term adverse
effects.
Points of regulation and potential disruption
An endocrine axis may possess numerous points of regu-
lation, including tissues within the central nervous system
that control the release of neurohormones, the pituitary gland,
other hormone-producing glands, and tissues responsible for
clearance of both tropic and peripherally derived hormones.
Biochemical pathways operating within these tissues provide,
in turn, a large number of potential molecular targets for
disruption of the axis. For a comprehensive listing of known
targets for chemicals that act on endocrine axes we refer the
reader to Diamanti-Kandarakis et al. [49].
From a risk assessment perspective, an important question
is whether the number of toxicologically important sites for
disruption of an endocrine axis (each of which would result
in a unique adverse outcome pathway) is large or small. All
three endocrine axes described in this report operate through
homologously structured nuclear receptors that recognize andbind the appropriate hormone. Receptors for both estrogen and
thyroid hormone have been shown to bind a substantial number
of compounds, and research is underway to predict this binding
from a quantitative analysis of chemical structure [50,51].
Chemicals may interact with other molecular components
of both axes, however. Examples from the environmental
toxicology literature include perchlorate inhibition of iodide
uptake by the thyroid gland (attributable to competitive inhib-
ition of the sodium–iodide symporter [25]); and inhibition of
aromatase (CYP19; an enzyme responsible for synthesis of
17b-estradiol from its androgen precursor testosterone) by
the model chemical fadrozole and the pesticide prochloraz
[30,52–54]. Whether these nonreceptor mechanisms of action
are relevant for a large number of compounds or constitute a
small but important response category remains to be deter-
mined. The answer to this question has obvious relevance,
however, for development of high-throughput testing programs
(e.g., what mechanisms does one evaluate?) as well as efforts to
build mechanistic models of the major endocrine axes (see later
sections).
Compared with the HPG and HPT axes, the HPA axis has
received little attention with respect to potential effects
of endocrine-disrupting compounds [55]. The HPA axis
depends on the activity of CYP enzymes for corticosteroid
biosynthesis. Therefore, like the HPG axis, the HPA axis is a
potential target for compounds that disrupt steroid biosynthesis.
In addition to its central role in coordinating organism
responses to stress, the HPA axis strongly impacts animal
development, and altered HPA function can lead to preterm
birth and intrauterine growth retardation, as well as changes in
developmental programming that lead to long-term health
consequences (see previous discussion). Indeed, of the three
endocrine axes described here, the HPA axis provides some of
the best-known examples of physiological accommodation to
nonchemical stressors. Presently, the potential for chemical
effects on the HPA axis represents an understudied field of
investigation.
Fitness costs associated with accommodation and recovery
The evolution of resistance to toxic chemicals has been
investigated in a variety of microorganisms, invertebrates,
plants, and vertebrate pest species. This work suggests that
initial emergence of a resistance trait is generally associated
with negative fitness costs for the resistant organisms (e.g.,
decreased growth or reproduction [56,57]). Termination of the
exposure at this time can be expected, therefore, to result in
disappearance of the trait from the population. If the exposure
is continued for an extended period, however, resistant pop-
ulations may exhibit compensatory evolution, and initial fitness
costs may be reduced or eliminated altogether [58,59]. Under
these circumstances, chemical resistance may become fixed
within a population.
As indicated previously, killifish that inhabit highly
contaminated sites may develop resistance to chemicals
present at those locations [3]. Recent work suggests that this
resistance is not associated with a negative fitness cost [60].
The mechanistic basis for chemical resistance in killifish
remains unclear. However, Meyer et al. [61] found that
laboratory-reared, first-generation offspring of feral killifish
from a highly contaminated site were resistant to PAH-
mediated CYP1A induction, whereas CYP1A induction in
second-generation offspring was similar to that of second-
generation offspring of killifish collected from clean
reference sites. Thus, although chemical resistance in killifish
Predicting impacts on vertebrate endocrine systems Environ. Toxicol. Chem. 30, 2011 47may develop over a long period, the underlying basis may be
independent of changes in the genome.
A number of endocrine-active compounds have been shown
to cause nonlethal effects that could be expected to reduce the
fitness of individual organisms. Examples include reduced
production of fertile eggs in female fish exposed to estrogen
receptor agonists such as EE2 [62] and decreased oocyte
production in fish exposed to fadrozole [52] or 17b-trenbolone
(an androgen receptor agonist [63]). In each of these studies,
the dose exceeded the animal’s ability to compensate for effects
on the target axis. Less well known is whether successful
accommodation to or recovery from a chemical exposure results
in fitness costs for the exposed organisms. Studies of
male zebrafish exposed to EE2 suggested that restoration of
normal gonadal histology after withdrawal of the compound
was accompanied by impacts on male fertility (see earlier
discussion). This is not surprising, given that the impacted
organ is the site of sperm formation. A more challenging
question is whether recovery from chemical effects on
nongonadal tissues can result in negative fitness costs, or
alternatively whether fitness costs are associated with long-
term accommodation that is not accompanied by any discern-
ible impact on tissues and organs. These questions are largely
unexplored, and efforts to address them would require the use
of long-term, low-level exposure protocols as well as sensitive
measures of reproductive success.
Computational modeling of endocrine systems
Mathematical modeling is a key component of strategies
proposed by the NRC for toxicity testing in the 21st century [5].
The authors of the report discussed how computational models
could be used to improve risk assessments for chemicals
and identified three complimentary modeling approaches: phys-
iologically based toxicokinetic (PBTK) modeling; toxicity
pathway modeling; and biologically based dose–response
(BBDR) modeling. Physiologically based toxicokinetic models
translate measured or predicted exposure information into
dose metrics that can be related to in vitro and in vivo testing
data. Because they are based on a mechanistic description of
processes responsible for chemical uptake, distribution, and
elimination, PBTK models provide a rational basis for extrap-
olating dosimetry information from tested to untested species
and among different dosing scenarios. A review of PBTK
modeling in fish was provided by Kleinow et al. [64].
As defined by the NRC, toxicity pathway models describe
molecular events at the subcellular level that result in the
expression of cellular toxicity. These models provide a mech-
anistic basis for interpreting the results of in vitro cellular
assays, and their development for major mechanisms of action
was viewed by the NRC as a relatively short-term goal. In
contrast, BBDR models relate toxicity pathway perturbations
to apical responses in intact animals. As such, BBDR
models encompass the potential complexity of a complete
biological system, including important susceptibility factors
(e.g., presence/absence of a detoxifying enzyme) and compen-
satory responses operating at the tissue, organ, and organ
systems levels. A toxicity pathway model can be viewed,
therefore, as a module that exists within the framework of
a BBDR model. The ultimate goal of this approach is to use
linked PBTK/BBDR models to predict toxic impacts on humans
from knowledge of in vitro chemical effects (preferably
obtained from human cell cultures) and a measured or hypothe-
sized exposure. Not surprisingly, the development of BBDR
models was viewed by the NRC as a longer-term goal.Because the needs of human health and ecological risk asses-
sors differ, we may expect that the role of mathematical models in
support of each activity also will differ. The workgroup therefore
discussed how mathematical models could be used to support
ecological risk assessments for compounds that impact endocrine
systems. Some of the resulting conclusions overlap with state-
ments made in the NRC report, whereas others are more pertinent
to ecological risk assessment and the science that supports it.
In the near term, computational models of endocrine
systems can be used to better understand the results of
whole-animal chemical exposures. The major challenge of
this type of modeling is to relate a specific molecular interaction
to a chain of events that leads to an adverse outcome. Progress
on the development of these models is likely to be iterative
and may require supporting data from a variety of in vitro and
in vivo studies. Because the modeled system is highly dynamic,
incorporating control elements that describe this behavior as
well as behaviors that occur as a response to chemical insults
will be necessary.
Models developed in this manner may have relatively little
value for quantitative extrapolation of toxicity test results
beyond the species and lifestage for which data were collected.
Nevertheless, these models could provide a basis for qualitative
comparisons among species. For example, demonstrating the
conservation of molecular targets and general system behavior
in multiple species may be important, because this implies that
chemicals impacting one species can be expected to impact
others in a similar manner. Alternatively, differences among
species with respect to a critical molecular target (presence/
absence of the target or important structural differences) may
explain observed differences in sensitivity.
As noted previously, chemical effects on endocrine systems
may be highly time dependent. This time dependence includes
the length of time before an exposure elicits a measurable effect
as well as the time before measured effects become manifested
as apical endpoints of regulatory concern, and is attributable
to attributes of the systems themselves (e.g., hormone storage
and the capacity for compensation) and the persistence of
genetic programs initiated by hormones. Models that incorpo-
rate these time dependencies could be used to improve the
design of test protocols, ensuring that tests capture the effects
of interest without incurring unnecessary costs.
Finally, the temporal nature of chemical effects on endocrine
systems must be viewed within the context of complex natural
systems. Mechanistic models of these processes could be
combined with relevant life-history information (e.g., timing
of metamorphosis or reproduction) and information on the
likely timing of a chemical exposure (e.g., application of a
pesticide within an agroecosystem) to optimize the design of
field sampling efforts.
Over time we anticipate the development of a suite of
validated BBDR models for key species, including those
selected as test animals to screen for chemicals with endocrine
disrupting activity (see following discussion). The use of these
models within a regulatory context would require in vitro test
systems, quantitative structure–activity approaches, or short-
term assays to identify chemicals with potential to impact
specific endocrine axes (initial prioritization). This information
would be used to determine which models were needed and
whether additional data were required to make predictions
(e.g., relating to exposure dynamics). The selected models
could then be used to predict species and life-stage sensitivities
and address questions related to possible accommodation and
recovery (see also Villeneuve and Garcia-Reyero [6]).
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modes of action represent a longer-term goal. This may not be
true, however, for endocrine systems. The need is for models
that adequately represent essential features of whole-organism
physiology and pathophysiology in the presence of toxicants
and that are sufficiently predictive. Fortuitously, computational
models possessing these attributes are fairly well developed—
particularly for mammals—in the systems physiology and
pharmacology literature, with perturbations represented primar-
ily by disease processes and drugs. Several of these models have
been used also to predict the toxicity of environmental
toxicants. Here we summarize published models for the
HPG, HPT, and HPA axes, emphasizing those that are based
on a mechanistic description of the underlying biology as well
as those developed to predict the effects of endocrine-active
chemicals in ecologically relevant species.
Models of the HPG axis. Models of the HPG axis have been
developed to predict plasma steroid hormones and vitellogenin
concentrations in male fathead minnows exposed to 17a-ethi-
nylestradiol and 17b-estradiol [65], as well as vitellogenin
concentrations in male sciaenid fish exposed to PCBs and Cd
[66]. A third model for fish was developed to describe normal
functioning of the HPG axis in salmon [67]. A model of the
HPG axis in rats was developed to simulate hormone levels
in testes and blood [68]. Models of the HPG axis in humans
have been developed to describe changes in luteinizing
hormone and testosterone concentrations after treatment with
the gonadotropin-releasing hormone agonist triptorelin, and
the gonadotropin-releasing hormone receptor blocker degarelix
[69], as well as the luteinizing hormone–releasing hormone
antagonist cetrorelix [70].
Models of the HPT axis. A generalized feedback control
system model of the HPT axis in humans was published by
Eisenberg et al. [71]. This model builds on work by the same
author [72] as well as earlier models by DiStefano for several
species (e.g., [73]). At the core of each model is a nonlinear, six-
compartment submodel that describes the distribution and
elimination of T3 and T4. A similar approach was used to
model thyroid hormone kinetics in fasted trout [74] and tilapia
[75]. Kohn et al. [76] linked a PBTK model for 2,3,7,8-
tetrachlorodibenzo-p-dioxin to a description of the thyroid
gland to simulate the effects of 2,3,7,8- tetrachlorodibenzo-p-
dioxin on thyroid hormones in the rat. A highly detailed model
of the human thyroid gland was published by Degon et al. [77].
The model was developed to describe the effect of dietary
iodide on thyroid hormone secretion, including the decrease
in hormone production that occurs when dietary iodide levels
are elevated. A BBDR model of the HPT axis in adult rats
was presented by McLanahan et al. [78] and was used to
simulate the effects of dietary iodide deficiency. This model
builds on earlier PBTK models for perchlorate-induced inhib-
ition of iodide uptake in rats and humans [79–81].
Models of the HPA axis. A feedback model of the HPA axis
in humans was developed to describe the pulsatile behavior of
this system as well as its delayed responsiveness to different
pathological conditions [82]. A similar model was used by
Bairagi et al. [83] to simulate the effects of different surgical
(e.g., adrenalectomy, hypophysectomy) and pharmacological
interventions (e.g., infusion of different hormones). Two addi-
tional models were developed to describe the oscillatory behav-
ior of HPA axis hormones [84,85]. A stability analysis showed
that these oscillations occur in response to an external pulse
activator [85,86]. A model that incorporates pituitary gluco-
corticoid receptor synthesis was used to describe the observedbistability of the HPA axis [87]. This model predicted the low
levels of cortisol seen in some stress-related disorders (e.g.,
chronic fatigue syndrome). To our knowledge, no models have
been developed to describe the HPA axis in ecologically
relevant species or the response of this system to environmental
contaminants
RESEARCH NEEDS
Short-term research needs (5–10 years)
Research is needed to improve current understanding of
endocrine axes in selected ecological animal models (e.g.,
sensitive life stages or species used for conventional chemical
hazard testing), as well as effects of endocrine-active chemicals
on these axes. Initially, the baseline dynamics of endocrine
systems under unstressed conditions must be well understood to
develop and calibrate computational models of the HPG, HPT,
and HPA axes. To maximize their utility for ecotoxicology,
these models should be structured to allow for prediction of
chemical effects from knowledge of specific molecular inter-
actions (e.g., chemical binding to a receptor). Once baseline
model outputs for selected species and endocrine axes have
been validated, dose–response relationships for apical and non-
apical endpoints after exposure to endocrine-active compounds
must be defined across multiple exposure and recovery dura-
tions to document the spectrum of possible effects (homeo-
stasis/allostasis ! allostatic change ! morbidity; Fig. 3).
These studies would have as complimentary goals the need
to determine whether these effects occur across a relatively
narrow or wide range of dose levels (thereby defining the risk
assessment challenge); evaluate how dose–response relation-
ships change with exposure or recovery duration; and incorpo-
rate chemical-specific dose–response relationships into
computational models of endocrine axes for selected species.
Once these species-, axes-, and chemical-specific relationships
have been integrated within a modeling framework, the models
may be used to predict individual-level impacts of endocrine-
disrupting compounds for different exposure concentrations and
durations.
Long-term research needs (10þ years)
Prediction of population-level impacts will require informa-
tion from multigenerational studies that addresses the potential
fitness costs of accommodation and recovery. Studies with
mammals have shown that prolonged allostatic change within
the HPA axis (as well as other physiological systems) can result
in production of new phenotypes, including several disease
states. Whether these or other manifestations of allostatic load
can be elicited in ecologically relevant species and whether such
changes have associated fitness costs are unknown. Other
studies with mammals suggest that chemical impacts on the
endocrine system of very young animals can cause develop-
mental programming that results in adverse health effects later
in life. Nonchemical stressors have been shown to impact
developmental programming in several ecologically important
taxa, and epigenetic mechanisms that underlie these changes
may play a key role in the response of individuals and pop-
ulations to changing environmental conditions [88]. The poten-
tial for adverse effects on these species because of chemical
impacts on developmental programming is largely unexplored.
These impacts could include both inappropriate developmental
responses and prevention of appropriate changes in response to
changing environmental conditions.
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tional models of endocrine axes to predict possible impacts on
fitness and, by extension, populations. This will require a
linkage of models described previously under Short-term
research needs with additional models that relate apical end-
points to organism fitness. Unlike mechanistic models for
individual endocrine axes, models that predict organism fitness
from apical endpoints are likely to be based, at least initially, on
empirical correlations.
An additional challenge will be to characterize and model
interactions among the major endocrine axes. For example,
corticosteroids produced by tadpoles during periods of environ-
mental stress are thought to synergize with thyroid hormones to
accelerate metamorphosis [19]. The ecotoxicological signifi-
cance of this type of interaction is essentially unknown.
Need for both standardized and nonconventional testing
The use of identical test species, reference chemicals, exper-
imental designs, and endpoints—such as studies conducted
according to hazard testing guidelines for chemical registra-
tions—will be critical for characterizing short- and long-term
responses after time-varying chemical exposures. Data from
well-defined experimental systems also are required to facilitate
the calibration and validation of computational models. Obtain-
ing much of this information may be possible by appropriate
modification of assays under development as part of the U.S.
Environmental Protection Agency’s (U.S. EPA) Endocrine
Disruptor Screening Program (http://www.epa.gov/endo/). In
response to 1996 congressional mandates (Bill number PL 104-
170 Food Quality Protection Act of 1996; 1996 Amendments
to the Safe Water Drinking Act, PL 104-182), the U.S.
EPA established the Endocrine Disruptor Screening Program
to identify chemicals with potential endocrine effects. Under
guidance from the Endocrine Disruptor Screening and
Testing Advisory Committee, the U.S. EPA designed and
implemented a two-tiered testing strategy. Short-term tier 1
in vitro and in vivo assays were selected to identify
chemicals that can disrupt the estrogen, androgen, or thyroid
hormone systems through classical endocrine-related modes
of action (e.g., estrogen receptor activation), whereas long-
term tier 2 assays were selected to assess the potential for
effects on reproduction and development over one or two
generations.
Although validation and peer review are nearly complete
for the tier 1 screening battery, tier 2 assays are still in develop-
ment. Proposed tier 2 assays include the amphibian develop-
ment/reproduction assay; avian two-generation assay; fish life-
cycle assay; and aquatic invertebrate life-cycle assay. As
currently envisioned, these assays include assessments of
morphological-, biochemical-, and molecular-based endpoints
that are linked to apical endpoints such as development, growth,
and reproductive fitness. These endpoints would be evaluated
under constant concentrations and exposure durations through-
out multiple life stages (including sensitive developmental
windows). In principle, modifying these assays to address
uncertainties pertaining to accommodation and recovery might
be possible. Alternatively, assays developed by the U.S. EPA
could be used as a basis for follow-up work that employs more
sophisticated exposure protocols. An important advantage of
this approach is that it would build on other data collected using
the same test system, increasing the environmental relevance of
these observations.
Finally, laboratory bioassays are generally conducted under
ideal conditions that control for experimental variables (e.g.,temperature, light) and chemical exposure duration. To better
define the limits of accommodation and recovery, and to
provide a stronger basis for relating test results to environ-
mentally relevant conditions, using nonconventional
approaches to evaluate effects of endocrine-disrupting com-
pounds will be necessary. For example, testing the effects of
chemicals on the HPT axis of fish under conditions under which
dietary iodide is restricted may be important. Similarly,
limitations on the amount of food provided to test animals
may help determine whether endocrine-active chemicals have
subtle effects on growth and fitness.
SUMMARY AND CONCLUSIONS
Toxicologists have long recognized the ability of animals to
accommodate and recover from chemical exposures. From
a governmental regulatory perspective, these responses com-
plicate efforts to establish acceptable levels of chemical expo-
sure and generate reliable risk assessment decisions. This report
presents the findings of a workgroup that was organized as part
of a SETAC Pellston Workshop [6]. The workgroup discussed
accommodation and recovery within the context of chemical
effects on vertebrate endocrine systems. This effort resulted
in an expansion of a vision for accommodation and recovery
that was provided in a recent NRC report [5]. The expanded
vision recognizes the possible emergence of new phenotypes
that arise from developmental programming or allostatic
changes that occur as a consequence of repeated cycles of
accommodation.
Research to define the limits and biological costs of accom-
modation and recovery using standardized test designs is
needed. Ecological risk assessors generally focus on the poten-
tial for chemicals to adversely affect animal populations. In
most cases, the fitness costs of successful accommodation and
recovery in individual organisms are unknown. An evaluation
of these fitness costs will require information from long-term
exposures, including multigenerational studies. Studies of
ecologically relevant species have shown that nonchemical
stressors acting on the HPA axis during early development
may cause changes in developmental programming. Additional
work with mammals has shown that exposure to endocrine-
active compounds during early development may result in
adverse health impacts that are not realized until adulthood.
Research is needed to determine whether chemical effects on
developmental programming represent an important mode of
action in ecotoxicology.
The workgroup strongly endorsed the development and
validation of mechanistically based computational models of
HPT, HPG, or HPA axes in ecologically relevant species to
better predict accommodation and recovery of endocrine sys-
tems, and as a basis for understanding the dynamics of these
systems in relation to complex environmental exposures. In the
short-term (5–10 years), these models can be used to design
experiments, interpret study findings, and predict the spectrum
of possible individual-level impacts of endocrine-disrupting
compounds for different exposure concentrations and durations.
Over the long-term (10þ years), a set of validated models could
be used to extrapolate limited in vitro and in vivo testing
data to a broader range of untested chemicals, species, and
exposure scenarios. With appropriate modification, tier 2 assays
developed in support of the U.S. EPA’s Endocrine Disruptor
Screening Program could be used to assess the potential for
accommodation and recovery, and to inform the development
of mechanistically based models.
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